医療装置ならびに医療産業

市場、技術レポート


●InteLab Corporation

Worldwide Markets and Emerging Technologies for Tissue Engineering and Regenerative Medicine
「組織工学及び再生医療の世界市場と振興技術」
#IL600
2009年1月発効、価格:$4,750(消費税別)





Major Topics
  • 組織工学および再生医療の技術
  • 心臓弁修復ならびに交換、心不全治療における心筋組織再生、および抹消血管疾患ならびに冠動脈疾患を含む組織工学ならびに再生医療の心臓血管用アプリケーションの市場分析
  • 軟骨修復ならびに交換、骨修復、靭帯および腱の修復ならびに交換、関節修復を含む整形用のアプリケーションならびに市場の解析
  • 脊髄損傷の修復、パーキンソン病、癲癇、多発性硬化症、末梢神経の傷害、卒中および中枢神経傷害を含む神経学的医療へのアプリケーション
  • 尿失禁、膀胱の修復、尿管および尿道の修復、陰茎再建および勃起不全の治療、ならびに膀胱尿管逆流現象、などの治療を含む泌尿器科アプリケーションの市場解析
  • 現行の臓器補助市場ならびに技術と肝臓、腎臓、心臓、膵臓、骨髄、および小腸交換の分析を含む臓器再生におけるアプリケーション
  • 創傷管理、皮膚修復および皮膚潰瘍の治療へのアプリケーション市場分析
  • 現状ならびに予測される市場の推移、価格のトレンド、および競争要因の分析
  • 代表的な取引、競合企業の戦略、ならびに技術プロフィールの解析
  • 40社の関連企業の詳細なプロフィール


Report published January 2009
価格: $4,750(時価換算円価格となります)

CONTENTS

EXECUTIVE SUMMARY

1. TISSUE ENGINEERING AND REGENERATIVE MEDICINE TECHNOLOGIES
1.1 Biomaterials Technologies
1.1.1 Synthetic Materials
1.1.2 Biologically Derived Materials
1.1.3 Genetically Engineered Materials
1.2 Stem Cell Technologies
1.2.1 Stem Cell Sources
1.2.2 Stem Cell Extraction Techniques
1.2.3 Stem Cell Expansion
1.2.4 Stem Cell Delivery
1.2.5 Existing and Development-Stage Stem Cell Products
1.3 Cell Culture Technologies
1.4 Immunopassivation and Immunomodulation
1.4.1 Chimeric Immunopassivation
1.4.2 Immunomodulation
1.4.3 Cell Encapsulation

2. CARDIOVASCULAR APPLICATIONS OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
2.1 Cardiovascular Disease Incidence and Prevalence
2.2 Cardiovascular Applications and Market Potential
2.2.1 Heart Valve Repair and Replacement
2.2.2 Heart Failure and Myocardial Tissue Regeneration
2.2.3 Applications in Peripheral Vascular Disease
2.2.4 Applications in Coronary Artery Disease
2.3 Market Forecast for Cardiovascular Applications
2.4 Cardiovascular Market Drivers and Limiters
2.5 Leading Companies in Cardiovascular Tissue Engineering and Regenerative Medicine

CHAPTER 3: ORTHOPAEDIC APPLICATIONS AND MARKETS
3.1 Orthopaedic Disease Incidence and Existing Therapies
3.1.1 Bone Fractures/Bone Repair and Replacement
3.1.2 Cartilage Degeneration and Repair
3.1.2.1 Osteochondral Allografts
3.1.2.2 Osteochondral Autograft Transfer System and Mosaicplasty
3.1.2.3 Autologous Chondrocyte Transplantation
3.1.2.4 Matrix-induced Autologous Chondrocyte Implantation
3.1.2.5 High Tibial Osteotomy
3.1.3 Meniscus Defects and Repair
3.1.4 Ligament and Tendon Injuries and Repair
3.1.5 Joint Degeneration and Destruction
3.1.6 Spinal Disc Degeneration and Repair
3.2 Emerging Tissue Engineering and Regenerative Medicine Technologies for Orthopaedic Applications and Markets
3.2.1 Bone Repair and Replacement
3.2.2 Cartilage Repair and Replacement
3.2.2.1 Cartilage Autograft Implantation System
3.2.2.2 Other Emerging Cartilage Repair and Replacement Technologies
3.2.3 Meniscus Repair and Replacement
3.2.4 Tendon and Ligament Repair and Replacement
3.2.5 Spinal Disc Repair and Replacement
3.2.6 Market Size, Market Potential and Forecast for Orthopaedic Applications
3.3 Market Drivers and Limiters
3.4 Leading Companies in Orthopaedic Tissue Engineering

CHAPTER 4: APPLICATIONS AND MARKETS IN NEUROLOGY
4.1 Neurological Disease Prevalence and Incidence
4.2 Tissue Engineering and Regenerative Medicine Technologies for Neurological Applications and Market Potential
4.2.1 Tissue Engineering and Regenerative Medicine for Spinal Cord Injury and Amytrophic Lateral Sclerosis
4.2.2 Cell Implants for Parkinson’s Disease
4.2.3 Cell Transplants for Epilepsy Treatment
4.2.4 Stem Cell Therapy for Multiple Sclerosis
4.2.5 Cell Therapy for Peripheral Nerve Injury
4.2.6 Tissue Engineering Therapies for Stroke
4.2.7 Tissue Engineering Therapies for Alzheimer’s Disease
4.2.8 Tissue Engineering and Cell Transplant Therapies for Central Nervous System Disorders
4.3 Market Forecast for Neurological Applications
4.4 Market Drivers and Limiters
4.5 Leading Companies in Neurological Tissue Engineering

CHAPTER 5: APPLICATIONS AND MARKETS IN UROLOGY
5.1 Urological Disease Incidence and Prevalence
5.2 Tissue Engineering and Regenerative Medicine Technologies for Urological Applications and Market Potential
5.2.1 Treatment of Urinary Incontinence and Bladder Repair
5.2.2 Ureter Repair and Replacement
5.2.3 Urethral Repair
5.2.4 Penile Reconstruction
5.2.5 Tissue Engineering for Treatment of Vesicoureteral Reflux
5.2.6 Gene Therapy for Urological Dysfunction
5.3 Market Forecast for Urological Applications
5.4 Market Drivers and Limiters
5.5 Leading Companies in Urological Tissue Engineering

CHAPTER 6: ORGAN REGENERATION TECHNOLOGIES AND MARKETS
6.1 Existing Products for Organ Supplementation
6.2 Organ Transplantation
6.3 Technologies for Organ Regeneration
6.3.1 Liver Regeneration
6.3.2 Pancreas and Islet Cell Regeneration
6.3.3 Kidney and Renal Tubule Regeneration
6.3.4 Small Intestine Regeneration
6.3.5 Bone Marrow Regeneration
6.3.6 Heart Regeneration
6.4 Emerging Markets for Organ Regeneration
6.5 Organ Regeneration Market Drivers and Limiters
6.6 Leading Companies in Organ Regeneration

CHAPTER 7: TISSUE ENGINEERING AND REGENERATIVE MEDICINE FOR WOUND MANAGEMENT, SKIN REPAIR AND SKIN ULCER TREATMENT
7.1 Wound and Skin Disease Incidence and Prevalence
7.2 Tissue Engineering and Cell Transplantation Technologies for Wound Management, Skin Repair and Skin Ulcer Treatment and Market Potential
7.2.1 Wound Management
7.2.2 Burn Treatment
7.2.3 Skin Ulcer Treatment
7.2.4 Hernia and Soft Tissue Repair
7.3 Market Analysis Forecast for Tissue Engineering and Regenerative Medicine Products for Wound Management, Skin Repair and Skin Ulcer Treatment
7.4 Market Drivers and Limiters
7.5 Competitor Analysis for Tissue Engineering and Regenerative Medicine Market for Wound Management, Skin Repair and Ulcer Treatment

CHAPTER 8: COMPETITOR ASSESSMENT
8.1 Overview of Tissue Engineering and Regenerative Medicine Companies
8.2 Acquisitions, Mergers and Partnerships to Improve Competitive Position
8.3 Technology Portfolio Analysis for Leading Tissue Engineering and Regenerative Medicine Companies

CHAPTER 9: COMPANY PROFILES
9.1 Aastrom Biosciences
9.2 Advanced BioHealing
9.3 Advanced Cell Technology
9.4 Aldagen
9.5 Arteriocyte
9.6 Athersys
9.7 Biofisica
9.8 Bioheart
9.9 BioMimetic Therapeutics
9.10 Cardium Therapeutics
9.11 CeraPedics
9.12 Cook Biotech
9.13 CrossCart
9.14 CryoLife
9.15 Cytograft Tissue Engineering
9.16 Cytori Therapeutics
9.17 Gamida Cell Ltd.
9.18 GeneGrafts
9.19 GenVec
9.20 Genzyme
9.21 Geron
9.22 Integra LifeSciences
9.23 International Stem Cell
9.24 Isolagen
9.25 LifeCell/Kinetic Concepts
9.26 Mesoblast
9.27 MicroIslet
9.28 Neuralstem
9.29 Novocell
9.30 Organogenesis
9.31 Orthopeutics
9.32 Osiris Therapeutics
9.33 Pluristem Therapeutics
9.34 ReGen Biologics
9.35 ReNeuron
9.36 Scil Technology
9.37 StemCells Inc.
9.38 StemCor Systems
9.39 Tengion
9.40 Tepha

APPENDIX – COMPANY LISTING


InteLab Corporation has served the needs of clients in the medical device and diagnostics industry worldwide since 1991. The company has published market studies covering numerous topics in the medical device and diagnostics industry, and has also performed proprietary market and technology assessments for a wide variety of medical product manufacturers worldwide.





お申し込み先:
日本総代理店
株式会社テクトラン
電話:0551-20-5530
FAX: 0551-20-5531
e-mail: info@techtran.co.jp
代表取締役社長:牧野宝留